ArticleEuropean journal of epidemiology2025

Generalizability of trial criteria on amyloid-lowering therapy against Alzheimer's disease to individuals with mild cognitive impairment or early Alzheimer's disease in the general population.

Jacqueline J Claus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.